title: Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?
authors.forename: D
authors.initials: D
authors.lastname: Tassinari
authors.forename: V
authors.initials: V
authors.lastname: Arcangeli
authors.forename: I
authors.initials: I
authors.lastname: Panzini
authors.forename: S
authors.initials: S
authors.lastname: Sartori
authors.forename: L
authors.initials: L
authors.lastname: Gianni
authors.forename: A
authors.initials: A
authors.lastname: Ravaioli
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D016685:Mitomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy
chemical_list: D000903:Antibiotics, Antineoplastic; D016685:Mitomycin; D005472:Fluorouracil